Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE The use of ±3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) is associated with cardiovascular complications and hyperthermia. EXPERIMENTAL APPROACH We assessed the effects of the α 1‐ and β‐adrenoceptor antagonist carvedilol on the cardiostimulant, thermogenic and subjective responses to MDMA in 16 healthy subjects. Carvedilol (50 mg) or placebo was administered 1 h before MDMA (125 mg) or placebo using a randomized, double‐blind, placebo‐controlled, four‐period crossover design. KEY RESULTS Carvedilol reduced MDMA‐induced elevations in blood pressure, heart rate and body temperature. Carvedilol did not affect the subjective effects of MDMA including MDMA‐induced good drug effects, drug high, drug liking, stimulation or adverse effects. Carvedilol did not alter the plasma exposure to MDMA. CONCLUSIONS AND IMPLICATIONS α 1‐ and β‐Adrenoceptors contribute to the cardiostimulant and thermogenic effects of MDMA in humans but not to its psychotropic effects. Carvedilol could be useful in the treatment of cardiovascular and hyperthermic complications associated with ecstasy use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale
Derogatis, L. R., Rickels, K., & Rock, A. F. (1976) · British Journal of Psychiatry · doi:10.1192/bjp.128.3.280 · Cited by 2,298 · cited 3×
“2278 British Journal of Pharmacology (2012) 166 2277–2288 The exclusion criteria included the following: (i) age <18 or >45 years; (ii) pregnancy determined by a urine test before each test session; (iii) body mass index <18.5 kg·m-2 or >25 kg·m-2; (iv) personal or family (first-degree relative) history of psychiatric…”
BackgroundMethodInfluentialOverflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
Esler, M., Jennings, G., Lambert, G., Meredith, I., Horne, M., & Eisenhofer, G. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.963 · Cited by 794 · cited 1×
“Plasma adrenaline is mainly derived from the adrenals, whereas plasma NA stems largely from transmitters released by sympathetic nerves and the escape of NA into the circulation (Esler et al., 1990; Eisenhofer et al., 1995).”
BackgroundPsychometric evaluation of the altered states of consciousness rating scale (OAV)
Studerus, E., Gamma, A., & Vollenweider, F. X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012412 · Cited by 683 · cited 2×
“Additionally, the 5-Dimensions of Altered States of Consciousness Scale [5D-ASC; (Dittrich, 1998; Studerus et al., 2010)] was applied 4 h after MDMA or placebo administration.”
BackgroundMethodThe Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577
The Symptom Check-List-90-R (SCL-90-R): A German validation study
Schmitz, N., Hartkamp, N., Kiuse, J., Franke, G. H., Reister, G., & Tress, W. (2000) · Quality of Life Research · doi:10.1023/a:1008931926181 · Cited by 430 · cited 3×
“…and Statistical Manual of Mental Disorders, 4th edition (Wittchen et al., 1997) supplemented by the SCL-90-R Symptom Checklist (Derogatis et al., 1976; Schmitz et al., 2000)]; (v) regular use of medications; (vi) chronic or acute physical illness assessed by physical examination,…”
BackgroundMethodInfluentialGender differences in the subjective effects of MDMA
Liechti, M. E., Gamma, A., & Vollenweider, F. X. (2001) · Psychopharmacology · doi:10.1007/s002130000648 · Cited by 360 · cited 3×
“…2277© 2012 The Authors British Journal of Pharmacology © 2012 The British Pharmacological Society elevates body temperature under controlled laboratory conditions in humans in the absence of permissive factors (Liechti et al., 2001; Freedman et al., 2005; Dumont and Verkes, 2006; Parrott, 2012).”
BackgroundResultSelf-citationDifferential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase
White, T. L., Justice, A. J. H., & de Wit, H. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00818-3 · Cited by 248 · cited 1×
“The female subjects were investigated during the follicular phase (day 2–14) of their menstrual cycle when the reactivity to amphetamines is expected to be similar to men (White et al., 2002).”
BackgroundLiechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00126-3 · Cited by 245 · cited 3×
“The 5-HT2A-receptor antagonist ketanserin inhibited the thermogenic effects of MDMA in rats (Shioda et al., 2008), mice (Di Cara et al., 2011) and humans (Liechti et al., 2000).”
BackgroundSelf-citationLiechti, M. E., & Vollenweider, F. X. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.348 · Cited by 236 · cited 1×
“MDMA mainly releases 5-HT, NA and dopamine (Rudnick and Wall, 1992; Liechti and Vollenweider, 2001; Verrico et al., 2007).”
BackgroundSelf-citationA review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
Dumont, G. J. H., & Verkes, R. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063271 · Cited by 149 · cited 2×
“…2277© 2012 The Authors British Journal of Pharmacology © 2012 The British Pharmacological Society elevates body temperature under controlled laboratory conditions in humans in the absence of permissive factors (Liechti et al., 2001; Freedman et al., 2005; Dumont and Verkes, 2006; Parrott, 2012).”
Background
Cited by
Pharmacological characterization of designer cathinones in vitro
Simmler, L., Buser, T., Donzelli, M., Schramm, Y., Dieu, L., Huwyler, J., Chaboz, S., Hoener, M., & Liechti, M. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02145.x · Cited by 672
Self-citationMDMA enhances emotional empathy and prosocial behavior
Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst161 · Cited by 356
Self-citationPsychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Richards, J. R., Albertson, T. E., Derlet, R. W., Lange, R. A., Olson, K. R., & Horowitz, B. Z. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.040 · Cited by 107
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review
Sarparast, A., Thomas, K., Malcolm, B., & Stauffer, C. S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06083-y · Cited by 88
Metadata
- Authors
- Hysek, C., Schmid, Y., Rickli, A., Simmler, L., Donzelli, M., Grouzmann, E., & Liechti, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2012-07-24
- Volume
- 166
- Issue
- 8
- Pages
- 2277-2288
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1581024190
- Cited by
- 82
- References
- 10
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. https://app.cochat.ai/papers/10.1111/j.1476-5381.2012.01936.x
- The paper
- Hysek, C., Schmid, Y., Rickli, A., Simmler, L., Donzelli, M., Grouzmann, E., & Liechti, M. (2012). Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2012.01936.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.